Pharmaceutical Contract Manufacturing And Research Services Market In-Depth Research On Basis Of Service, Region And Forecast To 2028


 San Francisco, 24 Aug 2021: The Report Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report By Service (Manufacturing, Research), By Region, And Segment Forecasts, 2021 - 2028

The global pharmaceutical contract manufacturing and research services market size is expected to reach USD 276.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.75% from 2021 to 2028. The rising investments in R&D, increasing demand for generics, and the growing aging population with various chronic diseases are responsible for market growth.

The focus of large pharmaceutical companies to strategically engage with a small number of preferred providers is a meaningful solution from procurement-based outsourcing. This was one of the many business traits that this service industry has become accustomed to. Service providers that hold the potential of providing cost and quality advantages are set to make inroads and grow at a tremendous pace in the forecast period.

However, drug manufacturers are increasing their investments with respect to production capabilities. This may limit the potential growth of contract manufacturing services to traditional customers, thereby hampering industrial growth. However, the COVID-19 pandemic has provided new opportunities for pharmaceutical contract manufacturing and research services. Because of this pandemic, the contract service sector has switched its focus towards manufacturing COVID-19 therapies and vaccines. For example, 42 contract manufacturing services have publicly disclosed for 26 unique pipeline COVID-19 vaccines that they shall manufacture. The majority of vaccine manufacturers have been seen to partner with CMOs in locations, such as the U.K., the U.S., and Germany.

Access Research Report of Pharmaceutical Contract Manufacturing And Research Services Market @ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-contract-manufacturing-market

Pharmaceutical Contract Manufacturing And Research Services Market Report Highlights

  • By service, the manufacturing segment dominated the market in 2020. In this segment, Active Pharmaceutical Ingredient (API) / bulk drugs held the largest revenue share in 2020. Pharmaceutical companies prefer outsourcing services for API research and manufacturing owing to the reduction in the cost of production of APIs
  • In the manufacturing service segment, finished dose formulations are expected to register the fastest CAGR from 2021 to 2028
  • The research service segment is further segmented based on therapeutic area, wherein oncology held a significant share in 2020 and is anticipated to maintain its lead in the coming years
  • CMOs/CDMOs with the ability to establish facilities in emerging countries are expected to drive the market. The contract service sector is in its infancy in countries, including Brazil. Russia, India, and China
  • Companies can position themselves for strong growth, given that demand is expected to expand rapidly in the coming years. Increased competitiveness in the contract service sector is anticipated to ultimately benefit the sector growth

List of Key Players of Pharmaceutical Contract Manufacturing And Research Services Market

  • Catalent
  • Pharmaceutical Product Development LLC
  • AbbVie
  • Baxter BioPharma Solutions
  • Patheon
  • Grifols International, S.A.
  • Dalton Pharma Services
  • Boehringer Ingelheim Biopharmaceuticals GmbH
  • Lonza AG

Access Press Release of Pharmaceutical Contract Manufacturing And Research Services Market @ https://www.grandviewresearch.com/press-release/global-pharmaceutical-contract-manufacturing-contract-research-market

 

Comments

Post a Comment

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Asia Pacific PoC Diagnostics Market  Analysis And Segment Forecasts To 2020 The Asia Pacific point of care (PoC) diagnostics market is expected to reach USD 5,427.1 million by 2020, according to a new study by Grand View Research, Inc. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of PoC products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expect
Read more

U.K. Point Of Sale Software Market To Expand Industry Growth At USD 1.05 Billion By 2028

Image
  San Francisco, 21 Jan 2022:   The Report  U.K. Point Of Sale Software Market  Size, Share & Trends Analysis Report By Application (Fixed POS, Mobile POS), By Deployment, By Organization Size, By End-user, And Segment Forecasts, 2021 - 2028 The global U.K. point of sale software market size is expected to reach USD 1.05 billion by 2028, expanding at a CAGR of 8.1% from 2021 to 2028, according to the new study conducted by Grand View Research, Inc. The integration of a Point-Of-Sale (POS) solution with capabilities such as sales reports monitoring, cash flow recording, product demand analysis, tracking delivery status, and inventory management ensure systematic functioning and upscaling of a business. The adoption of POS software is directly impacted by the demand for POS terminals, which is witnessing growth in demand due to changing lifestyles and government policies. However, the COVID-19 pandemic disrupted the industry's business, wherein retail stores, restaurants, and hot
Read more